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Background
Cardiac magnetic resonance (MR) imaging can identify
the presence of diffuse fibrosis in patients with myocar-
dial diseases using T1 mapping. We evaluated the post-
gadolinium T1 relaxation time in milliseconds (ms) in
patients with pulmonary hypertension compared to con-
trols to investigate for the presence of diffuse myocardial
fibrosis in this patient population.
Methods
Patients (n=19) with a clinical diagnosis or imaging find-
ings of pulmonary hypertension who underwent cardiac
MR between 1/1/2009 and 9/30/2014 were identified.
Controls (n=10) were referred for cardiac MR evaluation
to rule out ARVD due to family history or palpitations,
but with a normal cardiac MR examination. Both
patients and controls underwent cardiac MR with
delayed gadolinium enhancement. Post-contrast lock-
locker inversion recovery sequences were obtained
approximately 15 minutes following administration of
gadolinium. T1 values were measured in the ventricular
septum by placing a region of interest (ROI) that was
confined to the myocardium using a semiautomated
method. Manual correction was used to adjust ROIs
that included the blood-pool. Statistical analysis was
performed using Kruskal-Wallis equality-of-populations
rank test to compare the patient and control groups due
to data skewness.
Results
There was no significant difference in the age of patients
versus controls, with a mean patient age of 56 ± 11
years, and a mean control age of 48 ± 18 years (p=0.13).
Males comprised 53% of the patient group and 30% of
the control group. Of the nineteen patients with pul-
monary hypertension, two had primary pulmonary
hypertension, while the remaining patients had second-
ary pulmonary hypertension. The main causes of sec-
ondary pulmonary hypertension in this group were
heart failure, sarcoidosis, scleroderma, lupus, and conge-
nital heart disease. The median ventricular septal myo-
cardial T1 value in controls was 388 ms (interquartile
range 84 ms) while the median T1 value in patients was
343 ms (interquartile range 71 ms). The ventricular sep-
tal myocardial T1 values were significantly lower in
patients with pulmonary hypertension compared to con-
trols (p=0.026), suggesting the presence of diffuse myo-
cardial fibrosis.
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Figure 1 Post-gadolinium ventricular septal myocardial T1 values in
controls versus patients with pulmonary hypertension.
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Conclusions
The presence of significantly lower ventricular septal T1
values in patients with pulmonary hypertension as a
marker of fibrosis illustrates the ability of cardiac MR to
assess for diffuse myocardial disease in this population.
Cardiac MR may therefore serve as a non-invasive tool
to identify early left ventricular abnormalities in these
patients with the potential to inform prognosis and eval-
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